Lawrence Gerard Kelly, in Cozad, NE - Pharmacist

Lawrence Gerard Kelly, is a Pharmacist based in Cozad, Nebraska. Lawrence Gerard Kelly is licensed to practice in Nebraska (license number 10201) and his current practice location is 2101 O St Apt 209, Cozad, Nebraska. He can be reached at his office (for appointments etc.) via phone at (402) 699-8440.

NPI number for Lawrence Gerard Kelly is 1316438898 and his current mailing address is 2101 O St Apt 209, Cozad, Nebraska. He does not participate in medicare program and thus does not accept medicare assignments. His NPI Number is 1316438898.

Contact Information

	Lawrence Gerard Kelly,
	2101 O St Apt 209, Cozad, NE 69130-1077
	(402) 699-8440
	Not Available

Healthcare Provider's Profile

Full Name	Lawrence Gerard Kelly
Gender	Male
Speciality	Pharmacist
Location	2101 O St Apt 209, Cozad, Nebraska
Accepts Medicare Assignments	Does not participate in Medicare Program. He may not accept medicare assignment.

NPI Data:

NPI Number: 1316438898
Provider Enumeration Date: 05/21/2018
Last Update Date: 06/16/2018

Medical Identifiers

Medical identifiers for Lawrence Gerard Kelly such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1316438898	NPI	-	NPPES
10201	Other	NE	PHARMACY LICENSE

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
183500000X	Pharmacist	10201 (Nebraska)	Primary

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Lawrence Gerard Kelly is NOT enrolled with medicare and thus cannot prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Lawrence Gerard Kelly, 2101 O St Apt 209, Cozad, NE 69130-1077 Ph: (402) 699-8440	Lawrence Gerard Kelly, 2101 O St Apt 209, Cozad, NE 69130-1077 Ph: (402) 699-8440

News Archive

Zinc finger nucleases utilized for modifying hESCs and hiPSCs

Scientists from The Whitehead Institute used zinc finger nucleases (ZFNs) designed by Sangamo BioSciences, Inc., (Nasdaq: SGMO) to efficiently and precisely modify the genomes of human embryonic stem cells (hESCs) and induced pluripotent stem cells (hiPSCs).

Scientists develop new method to produce irradiated nanomaterials for medical applications

Under the leadership of Petr Cígler from the Institute of Organic Chemistry and Biochemistry and Martin Hrubý from the Institute of Macromolecular Chemistry, both of which are part of the Czech Academy of Sciences, a team of researchers has developed a revolutionary method for the easy and inexpensive production of irradiated nanodiamonds and other nanomaterials suitable for use in highly sensitive diagnostics of diseases, including various types of cancer.

Amber-tinted glasses may reduce insomnia severity

How do you unwind before bedtime? If your answer involves Facebook and Netflix, you are actively reducing your chance of a good night's sleep.

FAA's Public Access Defibrillation Program: Emergency University and HeartSine Technologies support

The Federal Aviation Administration (FAA) has announced its selection of Emergency University and HeartSine Technologies to provide nationwide Automated External Defibrillators (AEDs) and program management for ERT members.

Researchers explore association between SSRI exposure in late pregnancy and risk of PPHN

Use of antidepressants late in pregnancy has been controversial since the FDA issued a Public Health Advisory in 2006 warning that the use of antidepressants in late pregnancy may increase risk of persistent pulmonary hypertension of the newborn (PPHN), a condition that typically occurs in term or near-term infants and presents within hours of birth with severe respiratory failure requiring intubation and mechanical ventilation.

Lawrence Gerard Kelly, - Pharmacist in Cozad, NE